Entity
  • BioVersys AG

    Created in 2010
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    400 6,073
  • Activities

  • Entity types

  • Location

    Hochbergerstrasse 60C, 4057 Basel, Switzerland

    Basel

    Switzerland

  • Employees

    Scale: 11-50

    Estimated: 27

  • Engaged corporates

    2
    0 2
  • Added in Motherbase

    1 year, 11 months ago
Description
  • Value proposition

    Leadership in overcoming the antibiotic resistance crisis.

    BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields.

    By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our most advanced research and development programmes address nosocomial infections of Acinetobacter baumannii (BV100, Phase 2), and tuberculosis (BVL-GSK098, Phase 2) in collaboration with GlaxoSmithKline (GSK) and a consortium of the University of Lille. BioVersys is located in the TechPark in the thriving biotech hub of Basel.

    Antibiotic resistance, Small molecules, Nosocomial infections, Tuberculosis, AMR, and R&D

  • ▷▷ BioVersys | Saving Lives in Resistant Times » www.bioversys.com » Antimicrobial Resistance (AMR), TuberculosisHome - BioVersys

    Antibiotic-resistant germs are among the most important medical threats of our day and age. ▷ Find out more about our mission to tackle this challenge!

  • https://www.bioversys.com/
Corporate interactions BETA
Corporate TypeTweets Articles
J.P. Morgan J.P. Morgan
Bank
Other

11 Jan 2025


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

28 May 2024


Similar entities
Loading...
Loading...
Social network dynamics